Spots Global Cancer Trial Database for Intradermal, Fractional Dose of HPV Vaccines:
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Intradermal, Fractional Dose of HPV Vaccines:
Official Title: Immunogenicity of Fractional Dose of the Bivalent and Nonavalent Intradermal HPV Vaccines.
Study ID: NCT04235257
Interventions
Study Description
Brief Summary: This randomized phase IV trial compares fractional dose of bivalent HPV vaccine to fractional dose of nonavalent HPV vaccine among men and women aged 27-45 years in Seattle, Washington. Participants will have immune response assessed at baseline, 4 weeks, 6 months, 12 months, and 24 months.
Detailed Description:
Keywords
Eligibility
Minimum Age: 27 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
University of Washington Virology Research Clinic, Seattle, Washington, United States
Contact Details
Name: Anna Wald, MD
Affiliation: University of Washington
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
